University of Leeds researchers are part of a project to transform development and manufacturing in the UK’s pharmaceutical industry by introducing new digital design processes.
The £20.4 million ADDoPT (Advanced Digital Design of Pharmaceutical Therapeutics) program is a major four-year collaboration between the Government, industry and universities.
It is expected to reduce the development time and cost of innovative medicines and improve the competitiveness of the UK’s pharmaceuticals sector.
Professor Kevin Roberts, Brotherton Professor of Chemical Engineering at the University of Leeds, who will lead the Leeds team, said: “The days of the blockbuster drug are numbered. Many medicines that are coming through are more targeted and we need a streamlined development process to get them to market.